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Inflammation in the face of harming stimuli protects the
organism; as a result, it is an essential process for survival, in
which both innate and adaptive immunity are involved. This
process must be tightly controlled and terminated in order to
warrant the reestablishment of body homeostasis. Therefore,
activation of resident inflammatory cells and the recruitment
and modulation of migrating inflammatory cells must be
ceased. When failure in neutralising acute inflammation
occurs, there is augmented risk for the development of
chronic inflammation, leading to several metabolic conse-
quences. In the present special issue, original research studies
as well as review articles address the inflammatory process
as a key contributor to the development of disease. In addi-
tion, pharmacological and nonpharmacological therapies are
examined and the molecular and physiological mechanisms
of the treatments are discussed.
Among the 24 accepted articles, 5 focus on nutritional
therapy and inflammation (D. Estadella et al.; L. Ma et al.;
M. J. Kim et al.; S. Scolleta et al.; C. Cunha et al.).The selected
articles discuss the effects of the consumption of saturated
and trans fatty acids upon tissue lipotoxicity, the influence
of resveratrol on lung injury, the beneficial effect of genistein
on renal damage, the role of vitamin D in the resolution of
inflammation, and finally the capacity of green tea extract to
counteract the consequences of obesity.
The ability of exercise to modulate chronic inflammation
is the focus of two articles, the first of which discusses
the adaptive response of skeletal muscle to inflammation as
induced by eccentric overload resistance training (B. N. Ide
et al.), while the other considers exercise effects upon spinal
cord injury-associated low grade inflammation (E. S. Alves
et al.).
Pulmonary diseases and inflammation are the subject
debated in 8 from the total of 24 articles selected for this issue,
with special emphasis on the possible triggers of inflamma-
tion onset in the scenario (Y. Yang et al.; G. Karakiulakis et
al.; M. S. Duan et al.; Geve et al.; I. T. Lee et al.; P. Seidel et al.;
Y. Shimizu et al.; A. D. Yalcin et al.). In fact, asthma, emphy-
sema, and COPD are extensively discussed in this issue, and
studies concerning the effects of treatment with dimethyl
fumarate, anti-IgE; activation of muscarinic receptors of
immune cells; and proinflammatory signalling are reviewed.
Sleep disorders are also contemplated in articles (V. A.
Lemos et al.; D. Rosa et al.; Y. Jin et al.) that demonstrate
that sleep apnea contributes to the increased inflammatory
cytokine content, a response to hypoxia induced by high
altitude.
Finally, 3 studies investigate the role of PPAR, 41BB/4
1 BBL, and mitochondrial dysfunction in metabolic disease
(T. H. Tu et al.; F. Monsalve et al.; A. Herna´ndez-Aguilera
et al.). In addition, inflammation is discussed in the presence
of periodontal disease and endotoxaemic shock (J. D. Correˆa
et al.; A. Sampaio et al.).
Collectively, this issue aims at providing insight on the
role of acute and chronic inflammation in different diseases,
as well as at presenting recently proposed treatment strate-
gies.
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